Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Granger

Showing results (951-960 of 1,023) with videos related to

Pageof 103
Sort By:
Lancet (London, England)|October 6, 2012
Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trialRenato D Lopes, Sana M Al-Khatib, Lars Wallentin, et al.
Archives of Internal Medicine|January 16, 2008
Incidence and prognostic significance of thrombocytopenia in patients treated with prolonged heparin therapyGustavo B F Oliveira, Eric M Crespo, Richard C Becker, et al.
JAMA|March 6, 2023
Coordinated Care to Optimize Cardiovascular Preventive Therapies in Type 2 Diabetes: A Randomized Clinical TrialNeha J Pagidipati, Adam J Nelson, Lisa A Kaltenbach, et al.
Stat (International Statistical Institute)|January 2, 2023
The development of a mobile app-focused deduplication strategy for the Apple Heart Study that informs recommendations for future digital trialsAriadna Garcia, Justin Lee, Vidhya Balasubramanian, et al.
The New England Journal of Medicine|July 6, 2017
Declining Risk of Sudden Death in Heart FailureLi Shen, Pardeep S Jhund, Mark C Petrie, et al.
Lancet (London, England)|September 2, 2017
A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trialDragos Vinereanu, Renato D Lopes, M Cecilia Bahit, et al.
JAMA Network Open|July 23, 2021
Assessment of North American Clinical Research Site Performance During the Start-up of Large Cardiovascular Clinical TrialsAkash Goyal, Tony Schibler, Brooke Alhanti, et al.
American Heart Journal|December 24, 2024
Discontinuation of SGLT-2i and GLP-1RA among persons with Type 2 diabetes and atherosclerotic cardiovascular disease treated in US cardiology clinicsAdam J Nelson, Lisa A Kaltenbach, Darren K McGuire, et al.
American Heart Journal|December 6, 2021
Effects of long-term testosterone treatment on cardiovascular outcomes in men with hypogonadism: Rationale and design of the TRAVERSE studyShalender Bhasin, A Michael Lincoff, Shehzad Basaria, et al.
Stroke|May 15, 2020
Antithrombotic Treatment of Embolic Stroke of Undetermined Source: RE-SPECT ESUS Elderly and Renally Impaired SubgroupsHans-Christoph Diener, Ralph L Sacco, J Donald Easton, et al.
Pageof 103

Showing results (951-960 of 1,023) with videos related to

Sort By:
Pageof 103
Lancet (London, England)|October 6, 2012
Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trialRenato D Lopes, Sana M Al-Khatib, Lars Wallentin, et al.
Archives of Internal Medicine|January 16, 2008
Incidence and prognostic significance of thrombocytopenia in patients treated with prolonged heparin therapyGustavo B F Oliveira, Eric M Crespo, Richard C Becker, et al.
JAMA|March 6, 2023
Coordinated Care to Optimize Cardiovascular Preventive Therapies in Type 2 Diabetes: A Randomized Clinical TrialNeha J Pagidipati, Adam J Nelson, Lisa A Kaltenbach, et al.
Stat (International Statistical Institute)|January 2, 2023
The development of a mobile app-focused deduplication strategy for the Apple Heart Study that informs recommendations for future digital trialsAriadna Garcia, Justin Lee, Vidhya Balasubramanian, et al.
The New England Journal of Medicine|July 6, 2017
Declining Risk of Sudden Death in Heart FailureLi Shen, Pardeep S Jhund, Mark C Petrie, et al.
Lancet (London, England)|September 2, 2017
A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trialDragos Vinereanu, Renato D Lopes, M Cecilia Bahit, et al.
JAMA Network Open|July 23, 2021
Assessment of North American Clinical Research Site Performance During the Start-up of Large Cardiovascular Clinical TrialsAkash Goyal, Tony Schibler, Brooke Alhanti, et al.
American Heart Journal|December 24, 2024
Discontinuation of SGLT-2i and GLP-1RA among persons with Type 2 diabetes and atherosclerotic cardiovascular disease treated in US cardiology clinicsAdam J Nelson, Lisa A Kaltenbach, Darren K McGuire, et al.
American Heart Journal|December 6, 2021
Effects of long-term testosterone treatment on cardiovascular outcomes in men with hypogonadism: Rationale and design of the TRAVERSE studyShalender Bhasin, A Michael Lincoff, Shehzad Basaria, et al.
Stroke|May 15, 2020
Antithrombotic Treatment of Embolic Stroke of Undetermined Source: RE-SPECT ESUS Elderly and Renally Impaired SubgroupsHans-Christoph Diener, Ralph L Sacco, J Donald Easton, et al.
Pageof 103